ReviewPharmaceuticals (Basel, Switzerland)2025

Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology.

Iacob-Daniel Goje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.